Best alpha-Adrenergic Blocker for myocardial infarction
2 alpha-Adrenergic Blocker drugs used for myocardial infarction, ranked by our independent rating. Compare them with all treatments for myocardial infarction or the full alpha-Adrenergic Blocker class. Not medical advice — always consult a professional.
Quick answer: Of the 2 alpha-adrenergic blocker drugs we rate for myocardial infarction, all are available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for myocardial infarction; the right choice depends on your situation, so confirm it with your prescriber.
How alpha-adrenergic blocker work
Alpha-adrenergic blockers block the alpha-1 receptors that adrenaline-like signals use to tighten muscle in blood vessels and the prostate. This relaxes those muscles, lowering blood pressure and easing urine flow in men with an enlarged prostate.
Other drug classes for myocardial infarction
Top alpha-adrenergic blocker for myocardial infarction: 1. Coreg · 2. Coreg CR
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Tablet | Generic | $1 | View → | |
| 2 | Not yet rated | Prescription | Capsule | Generic | $1 | View → |
Full ranking · 2 drugs
coreg
PrescriptionFDA-sourced
Coreg (Carvedilol) is an alpha-adrenergic blocker used to treat Angina Pectoris, Heart Failure, Hypertension, Myocardial Infarction.
Pharmacy pays
From ~$0.51/30· 8 formscoreg cr
PrescriptionFDA-sourced
Coreg CR (Carvedilol Phosphate) is an alpha-adrenergic blocker used to treat Angina Pectoris, Heart Failure, Hypertension, Myocardial Infarction.
Pharmacy pays
From ~$0.51/30· 8 formsFrequently asked
- What is the best alpha-adrenergic blocker for myocardial infarction?
- Ratings are based on FDA regulatory recall-safety data — always consult a professional.
- Which alpha-adrenergic blocker drugs treat myocardial infarction?
- pharmaranks lists 2 alpha-Adrenergic Blocker products used for myocardial infarction, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.